Neuren Pharmaceuticals Limited, a biopharmaceutical company, develops drugs for the treatment of neurological disorders. It develops and commercializes DAYBUE (trofinetide) for the treatment of Rett syndrome in adults and pediatric patients 2 years of age and older, as well as in Phase 2 clinical tr... Neuren Pharmaceuticals Limited, a biopharmaceutical company, develops drugs for the treatment of neurological disorders. It develops and commercializes DAYBUE (trofinetide) for the treatment of Rett syndrome in adults and pediatric patients 2 years of age and older, as well as in Phase 2 clinical trial to treat Fragile X syndrome. The company also develops NNZ-2591, which has completed Phase 2 clinical trial for the treatment of Phelan-McDermid; and in Phase 2 clinical trial for the treatment of Angelman and Pitt Hopkins. In addition, it develops NNZ-2591, which is in preclinical trial stage for the treatment of Prader-Willi syndrome, Hypoxic Ischemic Encephalopathy, and SYNGAP1. The company was incorporated in 2001 and is based in Hawthorn East, Australia. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.03 | -7.23314606742 | 14.24 | 14.58 | 12.52 | 292042 | 13.69694481 | DE |
| 4 | 0.45 | 3.52664576803 | 12.76 | 14.72 | 12.29 | 319090 | 13.44388242 | DE |
| 12 | 1.63 | 14.0759930915 | 11.58 | 14.72 | 11 | 348973 | 12.50747518 | DE |
| 26 | -6.36 | -32.4987225345 | 19.57 | 21.04 | 11 | 393854 | 14.05588076 | DE |
| 52 | -0.64 | -4.62093862816 | 13.85 | 22.985 | 11 | 442776 | 16.16089138 | DE |
| 156 | 0.09 | 0.685975609756 | 13.12 | 170.09 | 8.61 | 515606 | 15.38533148 | DE |
| 260 | 11.91 | 916.153846154 | 1.3 | 170.09 | 1.245 | 450537 | 12.79974976 | DE |
1kgwxman
1分前
WhenLambo
3分前
NYATC
7分前
TightCoil
8分前
HoldHigh
9分前
jimr1717
12分前
uber darthium
12分前
mascale
15分前
Green Leaf Smoker
15分前
PRmaniac
15分前
BZ2
15分前
OrbitWitch50
16分前
The-Shadow
18分前
LiveFromThe416
20分前
Loungerr
20分前
j333
20分前
Split T
22分前
jhdf51
23分前
Investors3
24分前
Foogie88
24分前
WhenLambo
26分前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。